Citius Oncology (CTOR) EBT (2023 - 2026)
Citius Oncology (CTOR) posted quarterly EBT of -$26.8 million for Q1 2026, down 259.25% year-over-year from $16.9 million in Q1 2025, and down 409.33% quarter-over-quarter from -$5.3 million in Q4 2025.
Citius Oncology (CTOR) EBT (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported EBT for 4 consecutive years, with -$26.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 259.25% year-over-year to -$26.8 million; the TTM figure through Mar 2026 stood at -$41.9 million (down 13.24% YoY), while the FY2025 annual figure was -$23.7 million, down 15.22% from the prior year.
- EBT slipped to -$26.8 million in Q1 2026 per CTOR's latest filing, from -$5.3 million in the prior quarter.
- Across five years, EBT topped out at -$147922.0 in Q1 2023 and bottomed at -$26.8 million in Q1 2026.
- Historically, EBT has averaged -$7.4 million across 4 years, with a median of -$5.2 million in 2025.
- Annual changes were most pronounced in 2024 — EBT slumped 6867.44% — and 2025, when it surged 63.28%.
- Citius Oncology's EBT stood at -$4.6 million in 2023, then slumped by 39.52% to -$6.4 million in 2024, then increased by 17.59% to -$5.3 million in 2025, then plunged by 409.33% to -$26.8 million in 2026.
- Business Quant data shows CTOR's EBT at -$26.8 million in Q1 2026, -$5.3 million in Q4 2025, and -$4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Citius Oncology | 76.95 Mn | 76.95 Mn | 1.00 Mn | -9.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.84 Mn |
| Dec 31, 2025 | -5.27 Mn |
| Sep 30, 2025 | -4.73 Mn |
| Jun 30, 2025 | -5.11 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Dec 31, 2024 | -6.39 Mn |
| Jun 30, 2024 | -13.90 Mn |
| Mar 31, 2024 | -9.27 Mn |
| Dec 31, 2023 | -4.58 Mn |
| Sep 30, 2023 | -4.81 Mn |
| Jun 30, 2023 | -199,554.00 |
| Mar 31, 2023 | -147,922.00 |